June 2025: Still Overpatented, Still Overpriced
May 2025: Merck’s Scheme to Product Hop Keytruda
How Celgene and Bristol Myers Squibb Used Volume Restrictions to Delay Revlimid Competition
How Pharma and Its Consultants Abuse the Patent System
March 2025: We Need More Drug Patent Data
Investigating the pharmaceutical industry’s drug patenting practices
Feb 2025: Five Patent Predictions for 2025
Dec 2024: The Year in Patent Reform
Mar 2024: Why Current Legislation to Prevent Patent Thickets Are a Good Start — But Not Enough
Feb 2024: The Senate HELP Committee Takes Aim at Drug Patent Abuse